Skip to main content
Clinical Trials/NCT05464355
NCT05464355
Active, not recruiting
Not Applicable

Feasibility Study of the Use of Biomarkers to Detect Perioperative Brain Injury: the Association Between Serum Neurofilament Light Chains, Tau Proteins, Continuous Intra-operative Electroencephalography, and the Development of Post Operative Cognitive Dysfunction After Surgery

University of Oxford1 site in 1 country45 target enrollmentJanuary 5, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
University of Oxford
Enrollment
45
Locations
1
Primary Endpoint
Feasibility to conduct the study
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

Loss of cognitive function after major surgery is a significant risk in older people. It can occur acutely in the days after surgery as delirium or in months to years later as a persistent reduction in brain function termed neurocognitive decline. Together these conditions are called post operative cognitive dysfunction (POCD). They can be acutely distressing for patients and are associated with other problems after surgery.

The causes of post operative cognitive dysfunction are poorly understood. Studies have been limited by a lack of biomarkers to predict which patients are at high risk of developing POCD. Research suggests silent strokes occurring during surgery and different sensitivities to anaesthetic medicines are associated with POCD.

The project consists of a feasibility study to investigate markers that might predict people over 65 years old getting POCD. The first biomarker is a non-invasive monitor of anaesthetics effects on brain function called electroencephalography (EEG): The investigators will identify which EEG patterns predict delirium within five days surgery. The second set of biomarkers are two blood tests of proteins that increase after strokes: these are neurofilament light chains and tau proteins. The investigators will establish if these can be used to predict having POCD up to one year after surgery and long term cognitive impairment up to 5 years after surgery.

Registry
clinicaltrials.gov
Start Date
January 5, 2023
End Date
January 1, 2030
Last Updated
10 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Greater than or equal to 65 years of age
  • Having elective non-cardiac surgery under general anaesthesia
  • Anticipated to have at least 48 hours of inpatient admission
  • Able \& willing to give informed consent

Exclusion Criteria

  • Unable to participate in neurocognitive assessments
  • Presence of delirium prior to surgery
  • Contraindication to use of EEG electrodes (e.g. known allergy to a component of the electrodes)
  • Known history of severe traumatic brain injury
  • Learning disability specifically with a known structural brain lesion
  • Known history of dementia
  • Participants undergoing operations on the carotid artery

Outcomes

Primary Outcomes

Feasibility to conduct the study

Time Frame: 1 year after surgery

The total number of participants who are successfully recruited, receive the study procedures and complete both 90 day and 1 year follow up after surgery.

Secondary Outcomes

  • Postoperative delirium incidence and severity(Up to 5 days after surgery)
  • Long term cognitive impairment(Up to 5 years after surgery)
  • Days alive and at home up to 90 days after surgery(90 days after surgery)
  • Postoperative neurocognitive dysfunction and severity(Up to 1 year after surgery)
  • Change in neurofilament light chains and tau proteins levels pre- to post operatively(Up to 2 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials